This nomogram can be used to help newly diagnosed breast cancer patients assess the likelihood that their breast cancer has spread to the sentinel lymph nodes (SLN). It integrates clinical features (age, tumor characteristics, staging), imaging measurements (ultrasound, mammography, MRI), and pathology findings (tumor type, grade, receptor status) to generate a predicted probability. All fields marked with * are required.
Clinical Information
Imaging
Pathology

Predicted Probability of SLN Metastasis

0 Low Risk 0.5 High Risk 1

About This Prediction

This nomogram helps physicians and patients to accurately predict the likelihood that a patient's breast cancer has spread to the sentinel lymph nodes. The model was developed using a multimodal fusion deep learning architecture that integrates 35 clinical features and 20 pathological features extracted from a cohort of breast cancer patients. The calculated estimates include the risk of any tumor cells being found in the sentinel lymph nodes, including isolated tumor cells detected only on immunohistochemistry. Predictions are generated by processing clinical data (age, breast side, lesion distance, tumor count and location), imaging measurements (ultrasound, mammography, and MRI tumor dimensions, calcification status, breast density), clinical staging (cT stage, axillary ultrasound findings, and Chen-Dai distance), and pathological findings (tumor type, histological grade, ER, PR, HER2, LVI, and Ki67 status) through the trained neural network. This tool is intended for academic and research use only and should not be used as a substitute for clinical judgment.

User Guide